[65] Analysis using the TCGA data set including LSCC, HNSCC, CvSCC, and ESCC shows that MAP3K13 is amplified in 23% of clinical samples (Figure 4). This evidence concerns the gene MAP3K13 and esophageal squamous cell carcinoma.